Lenkowsky Adam

Lenkowsky Adam is listed in filings as EVP at Bristol-Myers Squibb Co. This profile follows SEC Form 4 activity through May 5, 2026, including 19 public disclosures. Recent filings connect the profile to Bristol-Myers Squibb Co (BMY). The current snapshot covers public activity from May 5, 2025 to May 5, 2026. Reported amounts are shown as $34.9K to $129.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.